117 related articles for article (PubMed ID: 890699)
1. A hypothesis concerning possible new derivatives of daunorubicin and adriamycin with enhanced DNA-binding properties.
Neidle S
Cancer Treat Rep; 1977 Aug; 61(5):928-9. PubMed ID: 890699
[No Abstract] [Full Text] [Related]
2. Interaction of new derivatives of daunorubicin and adriamycin with DNA.
Arlandini E; Vigevani A; Arcamone F
Farmaco Sci; 1977 May; 32(5):315-23. PubMed ID: 862886
[TBL] [Abstract][Full Text] [Related]
3. Relationship between effects on nucleic acid synthesis in cell cultures and cytotoxicity of 4-demethoxy derivatives of daunorubicin and adriamycin.
Supino R; Necco A; Dasdia T; Casazza AM; Di Marco A
Cancer Res; 1977 Dec; 37(12):4523-8. PubMed ID: 922737
[TBL] [Abstract][Full Text] [Related]
4. Relationship between activity and amino sugar stereochemistry of daunorubicin and adriamycin derivatives.
Di Marco A; Casazza AM; Gambetta R; Supino R; Zunino F
Cancer Res; 1976 Jun; 36(6):1962-6. PubMed ID: 773533
[TBL] [Abstract][Full Text] [Related]
5. New antitumor anthracyclines.
Arcamone F
Lloydia; 1977; 40(1):45-66. PubMed ID: 875639
[No Abstract] [Full Text] [Related]
6. DNA complexing antibiotics: daunomycin, adriamycin and their derivatives.
Marco A; Arcamone F
Arzneimittelforschung; 1975 Mar; 25(3):368-74. PubMed ID: 1174034
[TBL] [Abstract][Full Text] [Related]
7. Thiol-dependent DNA damage produced by anthracycline-iron complexes. The structure-activity relationships and molecular mechanisms.
Muindi J; Sinha BK; Gianni L; Myers C
Mol Pharmacol; 1985 Mar; 27(3):356-65. PubMed ID: 2983184
[TBL] [Abstract][Full Text] [Related]
8. Adriamycin (NSC-123127) and its analogs.
Henry DW
Cancer Chemother Rep 2; 1974 Dec; 4(4):5-9. PubMed ID: 4451911
[No Abstract] [Full Text] [Related]
9. Cellular pharmacology of N,N-dimethyl daunorubicin and N,N-dimethyl adriamycin.
Egorin MJ; Clawson RE; Ross LA; Bachur NR
Cancer Res; 1980 Jun; 40(6):1928-33. PubMed ID: 7371027
[No Abstract] [Full Text] [Related]
10. DNA topoisomerase II-mediated interaction of doxorubicin and daunorubicin congeners with DNA.
Bodley A; Liu LF; Israel M; Seshadri R; Koseki Y; Giuliani FC; Kirschenbaum S; Silber R; Potmesil M
Cancer Res; 1989 Nov; 49(21):5969-78. PubMed ID: 2551497
[TBL] [Abstract][Full Text] [Related]
11. The discovery of daunorubicin.
Di Marco A; Cassinelli G; Arcamone F
Cancer Treat Rep; 1981; 65 Suppl 4():3-8. PubMed ID: 7049379
[TBL] [Abstract][Full Text] [Related]
12. Studies of anthracycline--DNA complexes by circular dichroism.
Rizzo V; Penco S; Menozzi M; Geroni C; Vigevani A; Arcamone F
Anticancer Drug Des; 1988 Aug; 3(2):103-15. PubMed ID: 3165639
[TBL] [Abstract][Full Text] [Related]
13. Fate of DNA and its complexes with daunorubicin and adriamycin in rat fibroblasts [proceedings].
Noël G; Trouet A
Arch Int Physiol Biochim; 1977 Feb; 85(1):189-9. PubMed ID: 68743
[No Abstract] [Full Text] [Related]
14. Biochemical and pharmacological activity of novel 8-fluoroanthracyclines: influence of stereochemistry and conformation.
Animati F; Arcamone F; Bigioni M; Capranico G; Caserini C; De Cesare M; Lombardi P; Pratesi G; Salvatore C; Supino R; Zunino F
Mol Pharmacol; 1996 Sep; 50(3):603-9. PubMed ID: 8794900
[TBL] [Abstract][Full Text] [Related]
15. Electrostatic and non-electrostatic contributions to the binding free energies of anthracycline antibiotics to DNA.
Baginski M; Fogolari F; Briggs JM
J Mol Biol; 1997 Nov; 274(2):253-67. PubMed ID: 9398531
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and radioiodination of some daunorubicin and doxorubicin derivatives.
Ghirmai S; Mume E; Tolmachev V; Sjöberg S
Carbohydr Res; 2005 Jan; 340(1):15-24. PubMed ID: 15620662
[TBL] [Abstract][Full Text] [Related]
17. Adriamycin and daunorubicin disposition in the rabbit.
Bachur NR; Hildebrand RC; Jaenke RS
J Pharmacol Exp Ther; 1974 Nov; 191(2):331-40. PubMed ID: 4417723
[No Abstract] [Full Text] [Related]
18. Changes of activity of daunorubicin, adriamycin and stereoisomers following the introduction or removal of hydroxyl groups in the amino sugar moiety.
Di Marco A; Casazza AM; Dasdia T; Necco A; Pratesi G; Rivolta P; Velcich A; Zaccara A; Zunino F
Chem Biol Interact; 1977 Dec; 19(3):291-302. PubMed ID: 597963
[TBL] [Abstract][Full Text] [Related]
19. Intercalation with DNA is a prerequisite for daunomycin, adriamycin and its congeners in inhibiting DNAase I.
Facchinetti T; Mantovani A; Cantoni L; Cantoni R; Salmona M
Chem Biol Interact; 1978 Jan; 20(1):97-102. PubMed ID: 630649
[TBL] [Abstract][Full Text] [Related]
20. DNA base sequence preference for adriamycin and nogalamycin binding.
Choudhury K; Chakraborty R; Dhar TC; Neogy RK
Indian J Biochem Biophys; 1985 Jun; 22(3):166-72. PubMed ID: 4077090
[No Abstract] [Full Text] [Related]
[Next] [New Search]
